Australia’s Pharmaceutical Benefits Scheme (PBS) is under the spotlight as it faces mounting pressure to provide cheaper medicines to its citizens. The scheme, which has been a lifeline for many, is now at a critical juncture, with the government grappling to balance the need for affordable healthcare with the demands of pharmaceutical companies. This article delves into the complexities of the PBS, exploring the challenges it faces, the impact on patients, and the potential solutions on the horizon. The PBS: A Lifeline for Many The Pharmaceutical Benefits Scheme has been a cornerstone of Australia’s healthcare system, offering subsidised medicines to (Read more…)
Lesen Sie den vollständigen Artikel auf Papierkugel - All About Everything.